The legal status of CBD in Italy has undergone significant changes in recent years, with the latest developments creating a complex regulatory environment.
Current Legal Status
As of 2024, CBD oil derived from hemp with THC content below 0.2% is legal in Italy. However, the regulatory landscape remains complex due to recent government actions.
Key Points:
- In August 2023, the Italian Ministry of Health issued a decree classifying CBD as a narcotic substance. This decree was set to come into effect on September 21, 2023.
- However, on October 24, 2023, the Administrative Court (TAR Lazio) suspended the effectiveness of this decree, stating that CBD is not a psychoactive substance and should not be included in the list of narcotic substances.
- This suspension allowed the resumption of sales of CBD-based ingestible products in Italy, confirming the lawfulness of selling light cannabis products.
- CBD is considered a novel food by the EU Commission, meaning specific authorization is required under EU Regulation 2015/2283 for its use in food and food supplements.
- CBD can be used as an ingredient in cosmetics in Italy, provided the products comply with Regulation (EC) No 1223/2009 on cosmetic products.
Recent Regulatory Developments
The legal journey of CBD in Italy has been marked by several significant events:
- In August 2023, the Italian Ministry of Health issued a decree classifying CBD as a narcotic substance. This decree was set to come into effect on September 21, 2023, potentially restricting CBD commercialization and treating all CBD products as either narcotic substances or for medicinal use only.
- However, on October 24, 2023, the Administrative Court (TAR Lazio) suspended the effectiveness of this decree. The court stated that CBD is not a psychoactive substance and should not be included in the list of narcotic substances.
- This suspension allowed the resumption of sales of CBD-based ingestible products in Italy, confirming the lawfulness of selling light cannabis products.
- As of June 2, 2023, CBD is no longer considered a novel food by the EU Commission. This means no specific authorization is required under EU Regulation 2015/2283 for its use in food and food supplements.
CBD in Cosmetics and Food Products
CBD can be used as an ingredient in cosmetics in Italy, provided the products comply with Regulation (EC) No 1223/2009 on cosmetic products. This allows for a wide range of CBD-infused beauty and skincare products in the Italian market.
Regarding food products, the removal of CBD from the EU’s novel food list has simplified its use in edibles and supplements. However, businesses should still ensure compliance with all relevant food safety regulations.
Medical Use of CBD
Medical cannabis has been legal in Italy since 2007, marking an early adoption of cannabis-based medicines in Europe. Patients can obtain cannabis-based medicines, including CBD products, with a prescription from a licensed physician. The conditions eligible for treatment with medical marijuana include multiple sclerosis, chronic pain, glaucoma, Tourette’s syndrome, and nausea.
Despite the legalization, access to medical cannabis has been challenging due to supply issues and high costs. To address this, the Italian government mandated the army to produce a specific strain of medical cannabis in 2014, aiming to reduce costs and improve availability.
Historical Context
Italy’s relationship with cannabis and CBD has evolved significantly over the years. Before World War II, Italy was among the leading producers of hemp. However, hemp cultivation was prohibited until recently. When legal restrictions were lifted, fields of hemp with low THC content, known as “cannabis light,” started appearing across Italy. The production of hemp rose dramatically from 500 acres to 5000 acres.
In the 1990s, cannabis was considered a “soft drug” in Italy, subject to softer penalties for possession and use. The 2007 legalization of medical cannabis marked a significant shift in policy, although strict regulations on production and distribution remained in place.
Latest Legislative Proposals
On May 25, 2024, the Italian Government proposed an amendment to prohibit the cultivation and sale of cannabis inflorescences with THC content lower than 2% for non-industrial or non-medical uses. This proposal, if approved, would equate “light” cannabis (THC < 0.2%) with higher THC cannabis in terms of legality. This potential change highlights the ongoing debates and evolving nature of cannabis legislation in Italy.
Business Implications and Opportunities
The CBD market in Italy presents significant opportunities, but businesses must navigate a complex and changing regulatory environment. Companies should ensure their products meet the current THC content requirements and work with accredited dealers and suppliers who emphasize legal compliance.
The rise of e-commerce has further simplified access to CBD products for Italian consumers. Many CBD businesses in Italy are exploring online sales channels to reach a wider audience, both domestically and potentially internationally.
Italy’s CBD industry has been rapidly expanding in recent years, with a growing demand for CBD-related products. The country’s relatively competitive legal regime regarding CBD products has created plenty of opportunities for entrepreneurs to start CBD-oriented businesses.
Traveling with CBD to Italy
For tourists and visitors, traveling to Italy with CBD oil is permissible as long as it adheres to the legal THC limit. However, travelers should always carry necessary certificates or laboratory reports that verify the THC content of their products to avoid any issues with customs authorities.
Challenges and Future Outlook
Despite its growth, the CBD industry in Italy faces several challenges:
- There’s a pressing need for more comprehensive research to fully understand the benefits and risks associated with CBD use.
- The medical community continues to debate the expansion of conditions for which medical marijuana can be prescribed, potentially opening up new avenues for CBD use in healthcare.
- As the industry expands, regulations may need to evolve to address emerging challenges and opportunities. This could include updates to cultivation rules, product standards, or sales regulations.
- The European Food Safety Authority (EFSA) considers CBD a Novel Food, which presents certain regulatory hurdles. However, EFSA also recognizes CBD as generally safe, a stance that bodes well for the future of the industry in Italy and across Europe.
Despite these challenges, the future of CBD in Italy appears promising. Public opinion towards CBD is becoming increasingly favorable, and consumer interest continues to rise. Italy’s recent legislative changes suggest a continued openness to CBD, indicating a favorable environment for CBD businesses in the near future.
Conclusion
While CBD products remain legal in Italy as of 2024, the regulatory environment is subject to rapid changes. Italy’s progressive stance on CBD has positioned it as a leader in the European CBD market. The country’s decision to remove Cannabis Sativa L. from its list of narcotics and to recognize CBD as both a dietary supplement and a medicine demonstrates its forward-thinking approach.
The CBD industry in Italy looks set to continue growing as research progresses and regulations develop. Whether you’re a resident, a tourist, or a business owner, staying informed about CBD laws in Italy is essential.
Sources
- Italian Medicines Agency (Agenzia Italiana del Farmaco – AIFA): https://www.aifa.gov.it/
- Italian Ministry of Health (Ministero della Salute): http://www.salute.gov.it/
- European Commission: https://ec.europa.eu/food/safety/novel_food_en
- Italian Parliament (Parlamento Italiano): https://www.parlamento.it/
- Official Journal of the Italian Republic (Gazzetta Ufficiale): https://www.gazzettaufficiale.it/
- Administrative Court of Lazio (TAR Lazio): https://www.giustizia-amministrativa.it/
English 
German 
French 
Spanish 
Dutch